<VariationArchive RecordType="classified" VariationID="655760" VariationName="NC_000001.11:g.(?_156114909)_(156115284_?)del" VariationType="Deletion" Accession="VCV000655760" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-15" DateCreated="2020-04-09" MostRecentSubmission="2020-04-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="650534" VariationID="655760">
      <GeneList>
        <Gene Symbol="LMNA" FullName="lamin A/C" GeneID="4000" HGNC_ID="HGNC:6636" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="156082573" stop="156140081" display_start="156082573" display_stop="156140081" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="156052368" stop="156109879" display_start="156052368" display_stop="156109879" Strand="+" />
          </Location>
          <OMIM>150330</OMIM>
          <Haploinsufficiency last_evaluated="2016-01-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LMNA">Some evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2016-01-18" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=LMNA">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
        <Gene Symbol="LOC129931597" FullName="ATAC-STARR-seq lymphoblastoid silent region 1421" GeneID="129931597" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>1q22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="156114934" stop="156115023" display_start="156114934" display_stop="156115023" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NC_000001.11:g.(?_156114909)_(156115284_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" innerStart="156114909" innerStop="156115284" display_start="156114909" display_stop="156115284" variantLength="376" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" innerStart="156084700" innerStop="156085075" display_start="156084700" display_stop="156085075" variantLength="376" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.(?_156114909)_(156115284_?)del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.(?_156114909)_(156115284_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.(?_156084700)_(156085075_?)del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.(?_156084700)_(156085075_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000001.11:g.(?_156114909)_(156115284_?)del AND Charcot-Marie-Tooth disease type 2" Accession="RCV000812008" Version="2">
        <ClassifiedConditionList TraitSetID="12238">
          <ClassifiedCondition DB="MedGen" ID="C0270914">Charcot-Marie-Tooth disease type 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-01-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-01-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-04-09" MostRecentSubmission="2020-04-09">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">16407522</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17599607</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27066507</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="12238" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9467" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Charcot-Marie-Tooth disease type 2</ElementValue>
                <XRef ID="MONDO:0018993" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Charcot-Marie-Tooth, Type 2</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="12431" />
                <XRef ID="12431" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301532</ID>
                <ID Source="BookShelf">NBK1358</ID>
              </Citation>
              <XRef ID="64746" DB="Orphanet" />
              <XRef ID="C0270914" DB="MedGen" />
              <XRef ID="MONDO:0018993" DB="MONDO" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1846439" SubmissionDate="2020-02-06" DateLastUpdated="2020-04-09" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="5442956|MedGen:CN043576" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000952306" DateUpdated="2020-04-09" DateCreated="2019-08-14" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">27066507</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">17599607</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16407522</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon 1 of the LMNA gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 1 of the LMNA gene. This is expected to result in an absent or disrupted protein product. This variant has been reported to segregate with dilated cardiomyopathy (DCM) in a large multigenerational family, and has been also found in independent individuals affected with DCM and cardiac conduction defect (PMID: 16407522, 17599607, 27066507). Loss-of-function variants in LMNA are known to be pathogenic (PMID: 18585512, 18926329). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LMNA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.(?_156084700)_(156085075_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043576" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6933794</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1846439" TraitType="Disease" MappingType="XRef" MappingValue="CN043576" MappingRef="MedGen">
        <MedGen CUI="C0270914" Name="Charcot-Marie-Tooth disease type 2" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

